CT-Definable Subtypes of Chronic Obstructive Pulmonary Disease: A Statement of the Fleischner Society

Published Online:https://doi.org/10.1148/radiol.2015141579

Integration of visual characterization of emphysema and airway abnormalities with physiologic and quantitative CT assessment permits categorization of chronic obstructive pulmonary disease into distinct structurally and functionally defined subtypes.

The purpose of this statement is to describe and define the phenotypic abnormalities that can be identified on visual and quantitative evaluation of computed tomographic (CT) images in subjects with chronic obstructive pulmonary disease (COPD), with the goal of contributing to a personalized approach to the treatment of patients with COPD. Quantitative CT is useful for identifying and sequentially evaluating the extent of emphysematous lung destruction, changes in airway walls, and expiratory air trapping. However, visual assessment of CT scans remains important to describe patterns of altered lung structure in COPD. The classification system proposed and illustrated in this article provides a structured approach to visual and quantitative assessment of COPD. Emphysema is classified as centrilobular (subclassified as trace, mild, moderate, confluent, and advanced destructive emphysema), panlobular, and paraseptal (subclassified as mild or substantial). Additional important visual features include airway wall thickening, inflammatory small airways disease, tracheal abnormalities, interstitial lung abnormalities, pulmonary arterial enlargement, and bronchiectasis.

© RSNA, 2015

References

  • 1. Petty TL, Weinmann GG. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. National Heart, Lung, and Blood Institute Workshop Summary. Bethesda, Maryland, August 29–31, 1995. JAMA 1997;277(3):246–253.
  • 2. Fabbri LM, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J 2003;22(1):1–2.
  • 3. Friedlander AL, Lynch D, Dyar LA, Bowler RP. Phenotypes of chronic obstructive pulmonary disease. COPD 2007;4(4):355–384.
  • 4. Smith BM, Austin JH, Newell JD Jr, et al. Pulmonary emphysema subtypes on computed tomography: the MESA COPD study. Am J Med 2014;127(1):94.e7–e23.
  • 5. Klein JS, Gamsu G, Webb WR, Golden JA, Müller NL. High-resolution CT diagnosis of emphysema in symptomatic patients with normal chest radiographs and isolated low diffusing capacity. Radiology 1992;182(3):817–821.
  • 6. Mets OM, Schmidt M, Buckens CF, et al. Diagnosis of chronic obstructive pulmonary disease in lung cancer screening computed tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickening. Respir Res 2013;14(1):59.
  • 7. McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011;365(17):1567–1575.
  • 8. Müller NL, Staples CA, Miller RR, Abboud RT. “Density mask:” an objective method to quantitate emphysema using computed tomography. Chest 1988;94(4):782–787.
  • 9. Murata K, Itoh H, Todo G, et al. Centrilobular lesions of the lung: demonstration by high-resolution CT and pathologic correlation. Radiology 1986;161(3):641–645.
  • 10. Madani A, Zanen J, de Maertelaer V, Gevenois PA. Pulmonary emphysema: objective quantification at multi–detector row CT—comparison with macroscopic and microscopic morphometry. Radiology 2006;238(3):1036–1043.
  • 11. Coxson HO, Rogers RM, Whittall KP, et al. A quantification of the lung surface area in emphysema using computed tomography. Am J Respir Crit Care Med 1999;159(3):851–856.
  • 12. Schroeder JD, McKenzie AS, Zach JA, et al. Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease. AJR Am J Roentgenol 2013;201(3):W460–W470.
  • 13. Han MK, Bartholmai B, Liu LX, et al. Clinical significance of radiologic characterizations in COPD. COPD 2009;6(6):459–467.
  • 14. Johannessen A, Skorge TD, Bottai M, et al. Mortality by level of emphysema and airway wall thickness. Am J Respir Crit Care Med 2013;187(6):602–608.
  • 15. Galbán CJ, Han MK, Boes JL, et al. Computed tomography–based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med 2012;18(11):1711–1715.
  • 16. Mets OM, Buckens CF, Zanen P, et al. Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans. JAMA 2011;306(16):1775–1781.
  • 17. Gevenois PA, De Vuyst P, Sy M, et al. Pulmonary emphysema: quantitative CT during expiration. Radiology 1996;199(3):825–829.
  • 18. Mohamed Hoesein FA, Schmidt M, Mets OM, et al. Discriminating dominant computed tomography phenotypes in smokers without or with mild COPD. Respir Med 2014;108(1):136–143.
  • 19. Fain SB, Panth SR, Evans MD, et al. Early emphysematous changes in asymptomatic smokers: detection with 3He MR imaging. Radiology 2006;239(3):875–883.
  • 20. Gierada DS, Woods JC, Jacob RE, et al. Emphysema quantification in inflation-fixed lungs using low-dose computed tomography and 3He magnetic resonance imaging. J Comput Assist Tomogr 2010;34(5):773–779.
  • 21. Lutey BA, Lefrak SS, Woods JC, et al. Hyperpolarized 3He MR imaging: physiologic monitoring observations and safety considerations in 100 consecutive subjects. Radiology 2008;248(2):655–661.
  • 22. Sukstanskii AL, Yablonskiy DA. In vivo lung morphometry with hyperpolarized 3He diffusion MRI: theoretical background. J Magn Reson 2008;190(2):200–210.
  • 23. Mugler JP 3rd, Altes TA. Hyperpolarized 129Xe MRI of the human lung. J Magn Reson Imaging 2013;37(2):313–331.
  • 24. Halaweish AF, Moon RE, Foster WM, et al. Perfluoropropane gas as a magnetic resonance lung imaging contrast agent in humans. Chest 2013;144(4):1300–1310.
  • 25. Friedman PJ. Imaging studies in emphysema. Proc Am Thorac Soc 2008;5(4):494–500.
  • 26. Remy-Jardin M, Remy J, Gosselin B, Copin MC, Wurtz A, Duhamel A. Sliding thin slab, minimum intensity projection technique in the diagnosis of emphysema: histopathologic-CT correlation. Radiology 1996;200(3):665–671.
  • 27. Kim SS, Seo JB, Lee HY, et al. Chronic obstructive pulmonary disease: lobe-based visual assessment of volumetric CT by using standard images—comparison with quantitative CT and pulmonary function test in the COPDGene study. Radiology 2013;266(2):626–635.
  • 28. Mayo JR. CT evaluation of diffuse infiltrative lung disease: dose considerations and optimal technique. J Thorac Imaging 2009;24(4):252–259.
  • 29. Sieren JP, Newell JD, Judy PF, et al. Reference standard and statistical model for intersite and temporal comparisons of CT attenuation in a multicenter quantitative lung study. Med Phys 2012;39(9):5757–5767.
  • 30. Parr DG, Stoel BC, Stolk J, Nightingale PG, Stockley RA. Influence of calibration on densitometric studies of emphysema progression using computed tomography. Am J Respir Crit Care Med 2004;170(8):883–890.
  • 31. Newell JD Jr, Sieren J, Hoffman EA. Development of quantitative computed tomography lung protocols. J Thorac Imaging 2013;28(5):266–271.
  • 32. Sieren J, Hoffman EA, Baumhauer H, et al. CT imaging protocol standardization for use in a multicenter study: SPIROMICS [abstr]. In: Radiological Society of North America Scientific Assembly and Annual Meeting Program. Oak Brook, Ill: Radiological Society of North America, 2011; 262.
  • 33. Gierada DS, Bierhals AJ, Choong CK, et al. Effects of CT section thickness and reconstruction kernel on emphysema quantification relationship to the magnitude of the CT emphysema index. Acad Radiol 2010;17(2):146–156.
  • 34. Ley-Zaporozhan J, Ley S, Weinheimer O, et al. Quantitative analysis of emphysema in 3D using MDCT: influence of different reconstruction algorithms. Eur J Radiol 2008;65(2):228–234.
  • 35. Tschirren J, Hoffman EA, McLennan G, Sonka M. Segmentation and quantitative analysis of intrathoracic airway trees from computed tomography images. Proc Am Thorac Soc 2005;2(6):484–487, 503–504.
  • 36. Lo P, van Ginneken B, Reinhardt JM, et al. Extraction of airways from CT (EXACT’09). IEEE Trans Med Imaging 2012;31(11):2093–2107.
  • 37. Mets OM, Willemink MJ, de Kort FP, et al. The effect of iterative reconstruction on computed tomography assessment of emphysema, air trapping and airway dimensions. Eur Radiol 2012;22(10):2103–2109.
  • 38. Hersh CP, Washko GR, Estépar RS, et al. Paired inspiratory-expiratory chest CT scans to assess for small airways disease in COPD. Respir Res 2013;14(1):42.
  • 39. Boiselle PM, Michaud G, Roberts DH, et al. Dynamic expiratory tracheal collapse in COPD: correlation with clinical and physiologic parameters. Chest 2012;142(6):1539–1544.
  • 40. Kalender WA, Rienmüller R, Seissler W, Behr J, Welke M, Fichte H. Measurement of pulmonary parenchymal attenuation: use of spirometric gating with quantitative CT. Radiology 1990;175(1):265–268.
  • 41. Fuld MK, Grout RW, Guo J, Morgan JH, Hoffman EA. Systems for lung volume standardization during static and dynamic MDCT-based quantitative assessment of pulmonary structure and function. Acad Radiol 2012;19(8):930–940.
  • 42. Bankier AA, O’Donnell CR, Boiselle PM. Quality initiatives: respiratory instructions for CT examinations of the lungs: a hands-on guide. RadioGraphics 2008;28(4):919–931.
  • 43. Ley-Zaporozhan J, Ley S, Krummenauer F, Ohno Y, Hatabu H, Kauczor HU. Low dose multi-detector CT of the chest (iLEAD Study): visual ranking of different simulated mAs levels. Eur J Radiol 2010;73(2):428–433.
  • 44. Gietema HA, Müller NL, Fauerbach PV, et al. Quantifying the extent of emphysema: factors associated with radiologists’ estimations and quantitative indices of emphysema severity using the ECLIPSE cohort. Acad Radiol 2011;18(6):661–671.
  • 45. Zaporozhan J, Ley S, Weinheimer O, et al. Multi-detector CT of the chest: influence of dose onto quantitative evaluation of severe emphysema: a simulation study. J Comput Assist Tomogr 2006;30(3):460–468.
  • 46. Madani A, De Maertelaer V, Zanen J, Gevenois PA. Pulmonary emphysema: radiation dose and section thickness at multidetector CT quantification—comparison with macroscopic and microscopic morphometry. Radiology 2007;243(1):250–257.
  • 47. Regan EA, Hokanson JE, Murphy JR, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD 2010;7(1):32–43.
  • 48. Coxson HO, Dirksen A, Edwards LD, et al. The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study. Lancet Respir Med 2013;1(2):129–136.
  • 49. Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J 2008;31(4):869–873.
  • 50. Couper D, LaVange LM, Han M, et al. Design of the subpopulations and intermediate outcomes in copd study (SPIROMICS). Thorax 2014;69(5):491–494.
  • 51. Bankier AA, Schaefer-Prokop C, De Maertelaer V, et al. Air trapping: comparison of standard-dose and simulated low-dose thin-section CT techniques. Radiology 2007;242(3):898–906.
  • 52. Nishio M, Matsumoto S, Ohno Y, et al. Emphysema quantification by low-dose CT: potential impact of adaptive iterative dose reduction using 3D processing. AJR Am J Roentgenol 2012;199(3):595–601.
  • 53. Zach JA, Newell JD Jr, Schroeder J, et al. Quantitative computed tomography of the lungs and airways in healthy nonsmoking adults. Invest Radiol 2012;47(10):596–602.
  • 54. Hackx M, Bankier AA, Gevenois PA. Chronic obstructive pulmonary disease: CT quantification of airways disease. Radiology 2012;265(1):34–48.
  • 55. Lee YK, Oh YM, Lee JH, et al. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung 2008;186(3):157–165.
  • 56. Paré PD, Nagano T, Coxson HO. Airway imaging in disease: gimmick or useful tool? J Appl Physiol (1985) 2012;113(4):636–646.
  • 57. Xie X, de Jong PA, Oudkerk M, et al. Morphological measurements in computed tomography correlate with airflow obstruction in chronic obstructive pulmonary disease: systematic review and meta-analysis. Eur Radiol 2012;22(10):2085–2093.
  • 58. Lynch DA, Al-Qaisi MA. Quantitative computed tomography in chronic obstructive pulmonary disease. J Thorac Imaging 2013;28(5):284–290.
  • 59. McLean K. The histology of localized emphysema. Australasian annals of medicine. 1957;6(4):282–294.
  • 60. McLean K. The histology of generalized pulmonary emphysema. II. Diffuse emphysema. Australas Ann Med 1957;6(3):203–217.
  • 61. McLean KH. The histology of generalized pulmonary emphysema. I. The genesis of the early centrolobular lesion: focal emphysema. Australas Ann Med 1957;6(2):124–140.
  • 62. McLean KH. The macroscopic anatomy of pulmonary emphysema. Australas Ann Med 1956;5(2):73–88.
  • 63. Leopold JG, Gough J. The centrilobular form of hypertrophic emphysema and its relation to chronic bronchitis. Thorax 1957;12(3):219–235.
  • 64. Leopold JG, Gough J. Post-mortem bronchography in the study of bronchitis and emphysema. Thorax 1963;18:172–177.
  • 65. Hogg JC, Nepszy SJ, Macklem PT, Thurlbeck WM. Elastic properties of the centrilobular emphysematous space. J Clin Invest 1969;48(7):1306–1312.
  • 66. Foster WL Jr, Gimenez EI, Roubidoux MA, et al. The emphysemas: radiologic-pathologic correlations. Radiographics 1993;13(2):311–328.
  • 67. Foster WL Jr, Pratt PC, Roggli VL, Godwin JD, Halvorsen RA Jr, Putman CE. Centrilobular emphysema: CT-pathologic correlation. Radiology 1986;159(1):27–32.
  • 68. Hruban RH, Meziane MA, Zerhouni EA, et al. High resolution computed tomography of inflation-fixed lungs: pathologic-radiologic correlation of centrilobular emphysema. Am Rev Respir Dis 1987;136(4):935–940.
  • 69. Kim WD, Eidelman DH, Izquierdo JL, Ghezzo H, Saetta MP, Cosio MG. Centrilobular and panlobular emphysema in smokers: two distinct morphologic and functional entities. Am Rev Respir Dis 1991;144(6):1385–1390.
  • 70. Wyatt JP, Fischer VW, Sweet HC. Panlobular emphysema: anatomy and pathodynamics. Dis Chest 1962;41(3):239–259.
  • 71. Laurell CB, Eriksson S. The electrophoretic α1-globulin pattern of serum in α1-antitrypsin deficiency. Scand J Clin Lab Invest 1963;15(2):132–140.
  • 72. Perlmutter DH, Brodsky JL, Balistreri WF, Trapnell BC. Molecular pathogenesis of alpha-1-antitrypsin deficiency–associated liver disease: a meeting review. Hepatology 2007;45(5):1313–1323.
  • 73. Lehman A, Mattman A, Sin D, et al. Emphysema in an adult with galactosialidosis linked to a defect in primary elastic fiber assembly. Mol Genet Metab 2012;106(1):99–103.
  • 74. Stern EJ, Frank MS, Schmutz JF, Glenny RW, Schmidt RA, Godwin JD. Panlobular pulmonary emphysema caused by i.v. injection of methylphenidate (ritalin): findings on chest radiographs and CT scans. AJR Am J Roentgenol 1994;162(3):555–560.
  • 75. Copley SJ, Wells AU, Müller NL, et al. Thin-section CT in obstructive pulmonary disease: discriminatory value. Radiology 2002;223(3):812–819.
  • 76. Guest PJ, Hansell DM. High resolution computed tomography (HRCT) in emphysema associated with alpha-1-antitrypsin deficiency. Clin Radiol 1992;45(4):260–266.
  • 77. Heard BE. A pathological study of emphysema of the lungs with chronic bronchitis. Thorax 1958;13(2):136–149.
  • 78. Satoh K, Kobayashi T, Misao T, et al. CT assessment of subtypes of pulmonary emphysema in smokers. Chest 2001;120(3):725–729.
  • 79. Mets OM, van Hulst RA, Jacobs C, van Ginneken B, de Jong PA. Normal range of emphysema and air trapping on CT in young men. AJR Am J Roentgenol 2012;199(2):336–340.
  • 80. COPDGene CT Workshop Group, Barr RG, Berkowitz EA, et al. A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD 2012;9(2):151–159.
  • 81. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner society: glossary of terms for thoracic imaging. Radiology 2008;246(3):697–722.
  • 82. Gierada DS, Glazer HS, Slone RM. Pseudomass due to atelectasis in patients with severe bullous emphysema. AJR Am J Roentgenol 1997;168(1):85–92.
  • 83. Stern EJ, Webb WR, Weinacker A, Müller NL. Idiopathic giant bullous emphysema (vanishing lung syndrome): imaging findings in nine patients. AJR Am J Roentgenol 1994;162(2):279–282.
  • 84. Park JS, Brown KK, Tuder RM, Hale VA, King TE Jr, Lynch DA. Respiratory bronchiolitis–associated interstitial lung disease: radiologic features with clinical and pathologic correlation. J Comput Assist Tomogr 2002;26(1):13–20.
  • 85. Ooi GC, Khong PL, Chan-Yeung M, et al. High-resolution CT quantification of bronchiectasis: clinical and functional correlation. Radiology 2002;225(3):663–672.
  • 86. Grenier P, Mourey-Gerosa I, Benali K, et al. Abnormalities of the airways and lung parenchyma in asthmatics: CT observations in 50 patients and inter- and intraobserver variability. Eur Radiol 1996;6(2):199–206.
  • 87. Nakano Y, Wong JC, de Jong PA, et al. The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med 2005;171(2):142–146.
  • 88. Berger P, Perot V, Desbarats P, Tunon-de-Lara JM, Marthan R, Laurent F. Airway wall thickness in cigarette smokers: quantitative thin-section CT assessment. Radiology 2005;235(3):1055–1064.
  • 89. Kitaguchi Y, Fujimoto K, Kubo K, Honda T. Characteristics of COPD phenotypes classified according to the findings of HRCT. Respir Med 2006;100(10):1742–1752.
  • 90. Orlandi I, Moroni C, Camiciottoli G, et al. Chronic obstructive pulmonary disease: thin-section CT measurement of airway wall thickness and lung attenuation. Radiology 2005;234(2):604–610.
  • 91. Aziz ZA, Wells AU, Desai SR, et al. Functional impairment in emphysema: contribution of airway abnormalities and distribution of parenchymal disease. AJR Am J Roentgenol 2005;185(6):1509–1515.
  • 92. Hasegawa M, Nasuhara Y, Onodera Y, et al. Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173(12):1309–1315.
  • 93. Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974;291(15):755–758.
  • 94. Myers JL, Veal CF Jr, Shin MS, Katzenstein AL. Respiratory bronchiolitis causing interstitial lung disease: a clinicopathologic study of six cases. Am Rev Respir Dis 1987;135(4):880–884.
  • 95. Yousem SA, Colby TV, Gaensler EA. Respiratory bronchiolitis–associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 1989;64(11):1373–1380.
  • 96. Monick MM, Powers LS, Walters K, et al. Identification of an autophagy defect in smokers’ alveolar macrophages. J Immunol 2010;185(9):5425–5435.
  • 97. Hogg JC, Wright JL, Wiggs BR, Coxson HO, Opazo Saez A, Paré PD. Lung structure and function in cigarette smokers. Thorax 1994;49(5):473–478.
  • 98. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350(26):2645–2653.
  • 99. Gruden JF, Webb WR. CT findings in a proved case of respiratory bronchiolitis. AJR Am J Roentgenol 1993;161(1):44–46.
  • 100. Heyneman LE, Ward S, Lynch DA, Remy-Jardin M, Johkoh T, Müller NL. Respiratory bronchiolitis, respiratory bronchiolitis–associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process? AJR Am J Roentgenol 1999;173(6):1617–1622.
  • 101. Okada F, Ando Y, Yoshitake S, et al. Clinical/pathologic correlations in 553 patients with primary centrilobular findings on high-resolution CT scan of the thorax. Chest 2007;132(6):1939–1948.
  • 102. Remy-Jardin M, Edme JL, Boulenguez C, Remy J, Mastora I, Sobaszek A. Longitudinal follow-up study of smoker’s lung with thin-section CT in correlation with pulmonary function tests. Radiology 2002;222(1):261–270.
  • 103. Crausman RS, Ferguson G, Irvin CG, Make B, Newell JD Jr. Quantitative chest computed tomography as a means of predicting exercise performance in severe emphysema [published correction appears in Acad Radiol 1995;2(10):870]. Acad Radiol 1995;2(6):463–469.
  • 104. Eda S, Kubo K, Fujimoto K, Matsuzawa Y, Sekiguchi M, Sakai F. The relations between expiratory chest CT using helical CT and pulmonary function tests in emphysema. Am J Respir Crit Care Med 1997;155(4):1290–1294.
  • 105. Lee KW, Chung SY, Yang I, Lee Y, Ko EY, Park MJ. Correlation of aging and smoking with air trapping at thin-section CT of the lung in asymptomatic subjects. Radiology 2000;214(3):831–836.
  • 106. Matsuoka S, Kurihara Y, Yagihashi K, Hoshino M, Watanabe N, Nakajima Y. Quantitative assessment of air trapping in chronic obstructive pulmonary disease using inspiratory and expiratory volumetric MDCT. AJR Am J Roentgenol 2008;190(3):762–769.
  • 107. Mead J, Turner JM, Macklem PT, Little JB. Significance of the relationship between lung recoil and maximum expiratory flow. J Appl Physiol 1967;22(1):95–108.
  • 108. Macklem PT, Mead J. Resistance of central and peripheral airways measured by a retrograde catheter. J Appl Physiol 1967;22(3):395–401.
  • 109. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968;278(25):1355–1360.
  • 110. Yanai M, Sekizawa K, Ohrui T, Sasaki H, Takishima T. Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J Appl Physiol (1985) 1992;72(3):1016–1023.
  • 111. Washko GR, Lynch DA, Matsuoka S, et al. Identification of early interstitial lung disease in smokers from the COPDGene study. Acad Radiol 2010;17(1):48–53.
  • 112. Jin GY, Lynch D, Chawla A, et al. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. Radiology 2013;268(2):563–571.
  • 113. Lederer DJ, Enright PL, Kawut SM, et al. Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study. Am J Respir Crit Care Med 2009;180(5):407–414.
  • 114. Reddy TL, Mayo J, Churg A. Respiratory bronchiolitis with fibrosis: high-resolution computed tomography findings and correlation with pathology. Ann Am Thorac Soc 2013;10(6):590–601.
  • 115. Katzenstein AL, Mukhopadhyay S, Zanardi C, Dexter E. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum Pathol 2010;41(3):316–325.
  • 116. Yamada T, Nakanishi Y, Homma T, et al. Airspace enlargement with fibrosis shows characteristic histology and immunohistology different from usual interstitial pneumonia, nonspecific interstitial pneumonia and centrilobular emphysema. Pathol Int 2013;63(4):206–213.
  • 117. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J 2008;32(5):1371–1385.
  • 118. Murray TI, Boxt LM, Katz J, Reagan K, Barst RJ. Estimation of pulmonary artery pressure in patients with primary pulmonary hypertension by quantitative analysis of magnetic resonance images. J Thorac Imaging 1994;9(3):198–204.
  • 119. Ng CS, Wells AU, Padley SP. A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter. J Thorac Imaging 1999;14(4):270–278.
  • 120. Wells JM, Washko GR, Han MK, et al. Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med 2012;367(10):913–921.
  • 121. Lee HJ, Seo JB, Chae EJ, et al. Tracheal morphology and collapse in COPD: correlation with CT indices and pulmonary function test. Eur J Radiol 2011;80(3):e531–e535.
  • 122. Greene R, Lechner GL. “Saber-sheath” trachea: a clinical and functional study of marked coronal narrowing of the intrathoracic trachea. Radiology 1975;115(2):265–268.
  • 123. Gupta PP, Yadav R, Verma M, Agarwal D, Kumar M. Correlation between high-resolution computed tomography features and patients’ characteristics in chronic obstructive pulmonary disease. Ann Thorac Med 2008;3(3):87–93.
  • 124. Higuchi T, Takahashi N, Shiotani M, et al. Main bronchial diverticula in the subcarinal region: their relation to airflow limitations. Acta Radiol 2012;53(1):44–48.
  • 125. Miyara T, Oshiro Y, Yamashiro T, Kamiya H, Ogawa K, Murayama S. Bronchial diverticula detected by multidetector-row computed tomography: incidence and clinical features. J Thorac Imaging 2011;26(3):204–208.
  • 126. Sverzellati N, Ingegnoli A, Calabrò E, et al. Bronchial diverticula in smokers on thin-section CT. Eur Radiol 2010;20(1):88–94.
  • 127. Bafadhel M, Umar I, Gupta S, et al. The role of CT scanning in multidimensional phenotyping of COPD. Chest 2011;140(3):634–642.
  • 128. O’Brien C, Guest PJ, Hill SL, Stockley RA. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2000;55(8):635–642.
  • 129. Martínez-García MA, Soler-Cataluña JJ, Donat Sanz Y, et al. Factors associated with bronchiectasis in patients with COPD. Chest 2011;140(5):1130–1137.

Article History

Received July 16, 2014; revision requested September 2; revision received October 28; accepted November 24; final version accepted February 16, 2015.
Published online: May 11 2015
Published in print: Oct 2015